REDHILL BIOPHARMA LTD. Rightofuse Assets
REDHILL BIOPHARMA LTD. (RDHL) had Rightofuse Assets of $163.00 thousand as of 2025-06-30, per its 6-K filed 2025-09-05.
Financial Statements › Notes
ifrs-full:RightofuseAssets · last filed 2025-09-05
- 2025-06-30: Rightofuse Assets $163.00K.
- 2024-12-31: Rightofuse Assets $302.00K.
- 2024-06-30: Rightofuse Assets $469.00K.
- 2023-12-31: Rightofuse Assets $989.00K.
| Period end | Rightofuse Assets |
|---|---|
| 2025-06-30 | $163.00K 6-K · filed 2025-09-05 |
| 2024-12-31 | $302.00K 6-K · filed 2025-09-05 |
| 2024-06-30 | $469.00K 6-K · filed 2024-08-29 |
| 2023-12-31 | $989.00K 20-F · filed 2025-04-10 |
| 2023-06-30 | $2.01M 6-K · filed 2023-08-17 |
| 2022-12-31 | $6.69M 20-F · filed 2024-04-08 |
| 2022-06-30 | $7.19M 6-K · filed 2022-11-07 |
| 2021-12-31 | $3.65M 20-F · filed 2023-04-28 |
| 2021-06-30 | $4.29M 6-K · filed 2021-08-26 |
| 2020-12-31 | $5.19M 20-F · filed 2022-03-17 |
| 2020-06-30 | $5.23M 6-K · filed 2020-08-13 |
| 2019-12-31 | $3.58M 20-F · filed 2021-03-18 |
| 2019-06-30 | $4.00M 6-K · filed 2019-07-23 |
| 2019-01-01 | $1.67M 20-F · filed 2020-03-04 |